We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca, Cephalon to Pay $54 Million to Settle Medicaid Rebate Case
AstraZeneca, Cephalon to Pay $54 Million to Settle Medicaid Rebate Case
AstraZeneca and Cephalon have agreed to pay $54 million, plus interest, to settle allegations that they knowingly underpaid quarterly rebates owed to states under the Medicaid program.